Involvement of interleukin-18 in acute graft-versus-host disease in mice

Transplantation

Volumn 78, Issue 9, 2004, Pages 1245-1250

  Itoi, Hisayuki ^a   Fujimori, Yoshihiro ^a   Tsutsui, Hiroko ^a,b   Matsui, Kiyoshi ^a   Sugihara, Ayako ^a   Terada, Nobuyuki ^a   Hada, Toshikazu ^a   Kakishita, Eizo ^a   Okamura, Haruki ^a,b   Hara, Hiroshi ^a   Nakanishi, Kenji ^a,b  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Acute graft versus host disease; Cytotoxic T lymphocyte; Experimental transplantation; Hematopoietic stem cells; IL 18

Indexed keywords

CHEMOKINE RECEPTOR CXCR1; GAMMA INTERFERON; INTERLEUKIN 8;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOPATHOLOGY; IMMUNOPATHOGENESIS; IMMUNOREGULATION; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE ACTIVATION;

ACUTE DISEASE; ANIMALS; FEMALE; GRAFT VS HOST DISEASE; INTERLEUKIN-18; INTERLEUKIN-18 RECEPTOR ALPHA SUBUNIT; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-18; SURVIVAL RATE; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS;

EID: 8644252629     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000137934.25190.B9     Document Type: Article

References (30)

1. Nakanishi K, Yoshimoto Y, Tsutsui H, et al. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 2001; 19: 423.
2. Hyodo Y, Matsui K, Hayashi N, et al. IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor. J Immunol 1999; 162; 1662.
3. + effector T cells is differentially regulated by IL-18 and IL-12. J Immunol 1999; 162: 3202.
4. Kohyama M, Saijyo K, Hayasida M, et al. Direct activation of human CD8+ cytotoxic T lymphocytes by interleukin-18. Jpn J Cancer Res 1998; 89: 1041.
5. Hoshino K, Tsutsui H, Kawai T, et al. Generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor. J Immunol 1999; 162: 5041.
6. Seki E, Tsutsui H, Tsuji NM, et al. Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocytogenes in mice. J Immunol 2002; 169:3863.
7. Neighbors M, Xu X, Barrat F, et al. A critical role for interleukin 18 in primary and memory effector responses to Listeria monocytogenes that extends beyond its effects on interferon γ production. J Exp Med 2001; 194: 343.
8. Yoshimoto T, Takeda K, Tanaka T, et al. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-γ production. J Immunol 1998; 161: 3400.
9. + T cells during T helper (Th) 1/Th2 differentiation: Critical downregulatory role of IL-4. J Exp Med 2001; 194: 143.
10. Ferrara JL, Deeg HJ. Graft-versus-host disease. N Engl J Med 1991; 324: 667.
11. Krenger W, Hill GR, Ferrara JL. Cytokine cascades in acute graft-versus-host disease. Transplantation 1997; 64: 553.
12. Rus V, Svetic A, Nguyen P, et al. Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. J Immunol 1995; 155: 2396.
13. Williamson E, Garside P, Bradley JA, et al. IL-12 is a central mediator of acute graft-versus-host disease in mice. I Immunol 1996; 157: 689-699.
14. + T cells requires CD154 expression by Th cells in acute graft versus host disease. J Immunol 1999; 162: 4373.
15. Fujiraori Y, Takatsuka H, Takeraoto Y, et al. Elevated interleukin (IL)-18 levels during acute graft-versus-host disease after allogeneic bone marrow transplantation. Br J Haematol 2000; 109: 652.
16. Nakamura H, Komatsu K, Ayaki M, et al. Serum levels of soluble IL-2 receptor, IL-12, IL-18, and IFN-γ in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation. J Allergy Clin Immunol 2000; 106: S45.
17. Itoi H, Fujiraori Y, Tsutsui H, et al. Fas ligand-induced caspase-1-dependent accumulation of interleukin-18 in mice with acute graft-versus-host disease. Blood 2001; 98: 235.
18. Fujimori Y, Yoshiraoto T, Matsui K, et al. Increased expression of interleukin 18 receptor on T lymphocytes in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation. J Interferon Cytokine Res 2002; 22: 751.
19. + T cells during acute graft-versus-host disease in mice. J Interferon Cytokine Res 2004; 24:291.
20. Arnold D, Wasem C, Juillard P, et al. IL-18-independent cytotoxic lymphocyte activation and IFN-ã production during experimental acute graft-versus-host disease. Int Immunol 2002; 14: 503.
21. Zecchina G, Novick D, Rubinstein M, et al. Interleukin-18 binding protein in acute graft versus host disease and engraftraent following allogeneic peripheral blood stem cell transplants. J Hematother Stem Cell Res 2001; 10: 769.
22. Reddy V, Hill GR, Pan L, et al. G-CSF modulates cytokine profile of dendritic cells and decreases acute graft-versus-host disease through effects on the donor rather than the recipient. Transplantation 2000; 69: 691.
23. Blazar BR, Taylor PA, Snover DC, et al. Nonmitogenic anti-CD3F(ab')2 fragments inhibit lethal murine graft-versus-host disease induced across the major histocompatibility barrier. J Immunol 1993; 150: 265.
24. Sugimoto T, Ishikawa Y, Yoshimoto T, et al. Interleukin 18 acts on memory T helper cells type 1 to induce airway inflammation and hyperresponsiveness in a naive host mouse. J Exp Med 2004; 199: 535.
25. Theobalt M. The role of alloreactive cytotoxic and lymphokine-secreting T lymphocytes in the development of acute graft-versus-host disease. Transfus Sci 1994; 15: 189.
26. Okamoto I, Kohno K, Tanimoto T, et al. IL-18 prevents the development of chronic graft-versus-host disease in mice. J Immunol 2000; 164: 6067.
27. Sykes M, Szot GL, Nguyen PL, et al. Interleukin-12 inhibits murine graft-versus-host disease. Blood 1995; 86: 2429.
28. Sykes M, Romick ML, Sachs DH. Interleukin 2 prevents graft-versus-host disease while preserving the graft-versus-leukemia effect of allogeneic T cells. Proc Natl Acad Sci USA 1990; 87: 5633.
29. Brok HP, Heidt PJ, van der Meide PH, et al. Interferon-gamma prevents graft-versus-host disease after allogeneic bone marrow transplantation in mice. J Immunol 1993; 151: 6451.
30. Reddy P, Teshima T, Kukuruga M, et al. Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis. J Exp Med 2001; 194:1433.